Predictive value of baseline fdg-pet/ct for the durable response to immune checkpoint inhibition in nsclc patients using the morphological and metabolic features of primary tumors

HIGHLIGHTS

• who: Ken Kudura et al. from the Department of Nuclear Medicine, Sankt Clara Hospital, Basel, Switzerland Faculty of Medicine, University of Basel, Basel, Switzerland have published the research work: Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors, in the Journal: (JOURNAL) of 31/Dec/2021
• what: The authors aimed to investigate the predictive of baseline 2-deoxy-2-[18 F]fluoro-Dglucose positron emission tomography/computed tomography (FDG-PET/CT) for durable responses to immune checkpoint . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.